IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D.
IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

IPTLD® a Registered Trademark by Donato Perez Garcia,MD
Copyright ©1930-2017 Donato Perez Garcia.



Thursday, April 23, 2015

Dr. Donato's Special Guest at the KAT JAMES Show

Dr. Donato stars as special guest in the KAT JAMES show.


ABOUT THE SHOW
Kat James’ fast-paced new radio show comes to life with living snapshots of unfolding, dramatic transformation, straight from her acclaimed Total Transformation® programs and from her award-winning bestseller, The Truth About Beauty. Featuring leading experts and maverick pioneers, Kat’s show promises unprecedented living inspiration and cut-to-the-chase solutions to today’s most pressing health, quality-of-life, anti-aging, body image, and beauty concerns.

Click the link below:

Wednesday, April 22, 2015

日本での IPT

 Donato療法と言われていたもので、約85年ほど前にメキシコの軍医Donato Perez Garcia ,Sr.(1896-1971)によってDonato療法として始められたものです。
 最初は栄養補給とヒ素による梅毒治療が主でしたが、米国で息子のDonato Perez Garcia Belon, Jr.(1930-2000)とカナダ人Dr. Steven G Ayreによって研究、論文発表がなされ、世界に広がっていきました。
 現在、孫のDonato Perez Garciaによって継承され、癌治療や難治性感染症等の治療に利用されています
 インシュリンを使用することにより、がん細胞の薬剤透過性を高めるため、また細胞増殖のS期(DNA合成期)の数を増やす働きのため、抗がん剤を少量でも有効にきかせることができます。頻回に投与でき、寝ている癌が目覚めて分裂し始めてもすぐ殺すことができるし、多種類の癌細胞が含まれていても複数の抗がん剤を使うことができるので、効く確率も上がります。



IPT治療法

  1. 治療方法と抗癌剤決定の為、今までの治療経過がわかる資料、紹介状、レントゲン写真、検査データ等をできるだけ持参し、カウンセリングに来ていただきます。
  2. 治療開始が決まれば効果判定に必要な為、当院で採血、CT、レントゲン、PET検査等受けていただき、注射、開始日を決め、スタートします。
  3. 外来で治療できます。朝食をとらないで、軽食をもって来院します。
    血糖を測定し、インシュリン量を計算してインシュリンを注射し、点滴を開始します。therapeutic momentと言われるところで、少量の抗癌剤を何種類か注射します。糖分の入った抗癌作用のあるその他の薬剤を入れてある点滴を開始し、朝食を食べて、 点滴が終了したら血糖を測定し、問題ないことを確認し、帰っていただきます。
    何の抗癌剤の副作用のつらさもなく、帰宅できます。病状にもよりますが、原則として最初 は週2回注射し、3週間計6回打ち、以後は週1回注射し続け、2ヶ月前後で効果判定し、同じ抗癌剤で継続するかを検討します。初期で癌が消え、腫瘍マー カーが正常になればやめます。また末期癌で、癌が消えず大きさが抑えられ、腫瘍マーカーも抑えられた共存状態の場合は週1回を継続し、経過良好の場合は注 射の間隔を延ばして継続していきます。

Yes, IPT in Japan

Wednesday, April 8, 2015

Timing of cancer chemotherapy using IPTLD® is crucial for the success of treatment. By Donato Perez Garcia, MD (IPT/IPTLD® Professor)

Timing of cancer chemotherapy using IPTLD® is crucial for the success of treatment. By Donato Perez Garcia, MD (IPT/IPTLD® Professor)

Back in the year 1980, R. North an immunologist from the Trudeau Institute in New York and colleagues were able to produce immune cycling with tumor regression by directing chemotherapy to immune suppressor cells. He also reported that if chemotherapy was given at the wrong day and earlier, it will not work, instead the tumor will grow faster and will give the impression that the tumor was resistant to the chemotherapy drug. (Science Magazine,May 2010).

While several of the IPT doctors I have trained on Insulin Potentiation Therapy  (IPT)  and some patients who have a cancer recurrence are concerned with finding which chemotherapy drug will work best I tell them that to have a successful treatment of cancer depends on the accurate timing of delivering chemotherapy to match the fluctuation in each patient's immune system.

Not all cancer patients are cured by surgery, radiotherapy, biological therapies, alternative treatments, standard high dose chemotherapy or even low dose chemo. Some patients achieve a complete regression, others do not respond and others appear to have some level of clinical response.

Traditional cancer therapies affect some cancer cells but also normal cells and produce the well known side effects.

Today my Insulin Potentiation Therapy +Targeted Low Dose chemotherapy has been taking advantage of the immune system cycle using it regulatory mechanism by enhancing selectively the T cells in a cycle specific manner due to the actions of the insulin that acts as a modifier of the cell biologic response.
Since Donato Perez Garcia,MD (1896-1971) the inventor on this treatment for cancer and chronic degenerative diseases started to treat patients, he set the treatment appointments for every 7 days, this was back in the year 1930 for chronic degenerative diseases and in 1946 for cancer. He noted that patients had very good responses when they received their chemotherapy every 7 days. It was the time when observation and good clinical judgment played an important factor. His observations came to scientific support until the year 2009 when a team of Medical Doctors (Coventry,Ashdown,Quinn,Markovic,Yatomi-Clarke & Robinson) from  Department of Surgery & Tumor Immunology Laboratory, University of Adelaide, Royal Adelaide Hospital, Adelaide South Australia identified the homeostatic immune oscillations in cancer patients that CRP a protein indicated. This CRP is associated with inflammation and the activation of the immune system. (Journal of Translational Medicine 2009,7:102)

To my patients treated here in Tijuana,Baja California this means that they are receiving their chemotherapy protocol on the correct day, achieving the disruption of the regulatory circuits that protect the tumor cells.  With my IPTLD protocol my patients are also taking advantage of the induced and controlled hyperthermia that insulin produces and it is well known that a high body temperature also helps in the fight against cancer.
I started to treat cancer and chronic degenerative disease patients back in 1983 and during these 28 years or clinical practice I have seen several cancer patients that were initially treated with standard chemotherapy, responded well but later developed a cancer recurrence. Several of these patients who developed a metastases or recurrence were told that  they build chemo resistance. When I started to treat them using the low dose insulin that acts as a modifier of the cell biologic response with the same chemo drugs they received as their first treatment they all had a good response. No need to mention that the Greek test to detect chemotherapeutic drugs sensitivity was not available.
Conclusion it is more important to deliver your chemotherapy drug combination on the right time and day to match your immune system activity . It is a good help to know which drugs "can" "maybe" work by means of a chemo sensitivity test but definitely it is not critical to your treatment, because when the drugs are given on the right time and day the response is going to be a success.

SKYPE: 619-798-8017

Office (Tijuana,BC.Mexico): +51-664-635-1827